CONQUER™: the patient voice™ Named 2023 PM360 Pharma Choice Award Gold Winner for Direct to Consumer/Direct to Professional (DTC/DTP)
For the second time, CONQUER magazine, the premier forum for patients with cancer, named the winner for the finest, most impactful creative work as decided by popular vote from the entire industry.
Langhorne, PA — Amplity Health, a leading global medical and commercial partner to biopharmaceutical companies, today announced that PM360, a trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has once again named CONQUER™: the patient voice™ as the DTC/DTP Pharma Choice gold winner. CONQUER™: the patient voice™ magazine is the official patient publication of the Academy of Oncology Nurse & Patient Navigators (AONN+), an association managed by Amplity Health.
The winning advertisement was produced to promote an interview published in CONQUER’s Breast Cancer Special Issue Series, Education, Advocacy, and Empowerment Bloom Eternal at Tigerlily Foundation: An interview with Maimah Karmo about her life’s work of empowering young women with breast cancer. In this article, Ms Karmo speaks about the importance of advocacy and the changes she’s seen in oncology care during her 16 years as a survivor.
“Most people have been touched by cancer in some way,” said Kristin Siyahian, Editorial Director for CONQUER’s breast cancer special issue series. “Keeping our personal experiences at the core of this project, we worked with physicians, navigators, advocacy groups, and survivors to create genuine words of encouragement and meaningful resources for patients with breast or endometrial cancer with the intention of providing hope. Receiving this recognition from the pharma industry is such a special honor because it was a truly inspired project.”
Since 2009, the PM360 Pharma Choice awards have served as the only industry awards to recognize outstanding achievement and creativity in healthcare and life sciences marketing by allowing the industry as a whole to choose the winners.
“CONQUER magazine’s mission is to help patients, their family members, and caregivers manage the complexities of cancer care treatment,” explained Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, AONN+’s Program Director. “It is an honor to be recognized by a cross section of experts throughout the industry as a leader for enriching the lives of consumers and patients in education to promote shared decision making in their cancer journey.”
All submissions are placed online where anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8,500 votes were cast to decide the winners.
“The best critics are the people who understand your circumstances, challenges, and ultimately what it takes to be successful. In life sciences marketing, that description can only apply to other life sciences marketers, which is why we give each and every marketer in this industry the opportunity to decide what can be called the best campaigns of the year,” said Anna Stashower, CEO/Publisher/Editor-in-Chief, PM360. “It is also what makes winning one of our Pharma Choice awards so significant, because it is an honor bestowed upon marketers by their peers—the only people who truly can comprehend just how hard it is to be creative, imaginative, engaging, captivating, and memorable in a highly regulated industry. These winning campaigns and initiatives didn’t just leave an impression on their intended audience, but on the people in the industry responsible for creating them day in and day out.”
In total, 42 winners were named in 14 distinct categories. The winning work is featured in the January/February 2023 issue of PM360, and can be viewed online at www.pm360online.com/2023-pm360-pharma-choice-award-winners.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision-making, including: planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
CONQUER™: the patient voice™ magazine (www.conquer-magazine.com) is the Academy of Oncology Nurse & Patient Navigators (AONN+) premier forum for patients with cancer. CONQUER features articles written by and for patients with cancer, survivors, nurse navigators, and other oncology team members. This magazine addresses the issues that patients, their family members, and caregivers face every day in an easy-to-read format. Issues include interviews with patients with cancer, information on access to care, and articles on lifestyle topics such as nutrition, stress management, personal finance, and legal and employer issues. CONQUER also features patient stories that are nominated for the AONN+ Hero of Hope™ award, which is presented at the AONN+ Annual Conference. All stories are compiled in a special issue of CONQUER at the end of the year.
About the Academy of Oncology Nurse & Patient Navigators® (www.aonnonline.org)
The Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. The organization, which has nearly 8,900 members, was founded in 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services in order to better manage the complexities of the cancer treatment process.
The Journal of Oncology Navigation & Survivorship® (JONS; www.jons-online.com) is the official publication of AONN+. JONS seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
About Amplity Health
The true partner of global healthcare companies, Amplity Health delivers tailored medical and commercial solutions that scale throughout the life cycle of your drug. Amplity is a global authority in scientific stakeholder engagement, go-to-market strategies, and is built upon our belief in the power of face-to-face interaction that nurtures trust with physicians, patients, and payers, allowing for the exchange of complex ideas. We are proud of our inclusive culture and our EPIIC values. Amplity has the expertise, global infrastructure, and data-driven insights to help clients overcome their medical and commercial challenges. Amplity’s wide-ranging capabilities include clinical and medical outsourced teams; clinical and medical capability development; companion diagnostic and precision medicine solutions; medical communications; expert engagement; remote and field solutions for patients, payers, and physicians; and strategic and access consulting. Amplity’s one-of-a-kind Insights database offers clients a detailed view into patient–provider interactions and provider treatment rationale not found through any other provider. For more information, visit amplity.com. Connect with Amplity on Twitter and LinkedIn. Amplity Health is a portfolio company of Altamont Capital Partners.
About Altamont Capital Partners
Altamont Capital Partners is a private investment firm based in the San Francisco Bay Area with more than $3.5 billion of assets under management. Altamont is focused on investing in middle market businesses where it can partner with leading management teams to help its portfolio companies reach their full potential. The firm’s principals have significant experience building business success stories across a range of industries, including healthcare, business services, financial services, consumer/retail, and industrials.
For Immediate Release
Gwen Coverdale, 267-884-6328